The US Food and Drug Administration (FDA) has recently approved a breakthrough new drug for the treatment of adult kidney disease, marking a significant milestone in the prevention and treatment of chronic kidney disease (CKD). This new therapy is about to completely change the treatment pattern of chronic kidney disease. I have already broadcasted this news on CNN News last week, but I still want to write this article on Facebook to tell more people who haven't seen the
Has anyone heard of Klotho? Or is this a scam?
REVITAHEPA™Renal Awakening Drop【Healthy 🥬, Pain-free 🌟, Non-recurrent 🏆】🥬 The bottle is 30 ml and cost $40
Written by
horsie63
To view profiles and participate in discussions please or .
it sounds like manipulation....ii havent found any other reference to klotho but id be cautious either way.if this was such a breakthrough drug big pharma would be selling it for more than 40 a bottle.
True but famous doctors do endorse products sometimes. Not talking Dr Oz famous. As I said I wouldn't take it based on what I read but would keep an eye and see what happens.
It’s likely a scam, but The US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anaemia due to chronic kidney disease (CKD) in adults
Thanks for bringing this up, Horsie! This is a very intriguing and promising field of study. Your post led me to research it and I discovered Klotho is an anti-aging membrane protein predominately produced in the kidneys. This came as a complete surprise to me - not only are kidneys responsible for filtering and producing hormones, but also Klotho! Who knew? Anyway, Klotho is essential for life - a lack of it has a profound influence on diabetes, cardiovascular health, brain health, and even kidney health. It's heavily linked to organ and muscle protection and a lack of it can lead to organ injury, early death, etc. The problem is that the field is very new and there are many Klotho phenotypes. Hence, therapies developed so far have been inconclusive. But, with additional funding and new approaches into formulas and therapies, the field holds significant promise. While proteins get a thumbs down here and there, they're very important - in the case of Klotho for protecting organs and muscles from deterioration. (I'm still wrapping my head around the fact that it's largely produced inside one's very own kidneys....) Anyway, this is great research report from the field of gerontology explaining the situation. ncbi.nlm.nih.gov/pmc/articl...
I go for my meeting with the transplant nephrologist on the 21st and plan to bring this up. I know from the biopsy my kidneys are damaged so I don't think even this would help BUT when I get the transplant perhaps I can keep her happy for a long time.
The key point is how to either activate it in the body or is the drug Dr. Gupta advocates a way to get it. Guess I'll wait and watch.
Exactly. And I believe you also have a genetic issue - maybe help with that too. Sheesh - I just love seeing promising things out there. I hope funding for the sciences strengthens as the years go by fast. It's the only way a lot of diseases will be fixed.
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group
Klotho, a multifunctional protein, acts as a co-receptor in fibroblast growth factor 23 and exerts its impact through various molecular pathways, including Wnt, hypoxia-inducible factor and insulin-like growth factor 1 pathways. The physiological significance of Klotho is the regulation of vitamin D and phosphate metabolism as well as serving as a vital component in aging and neurodegeneration. The role of Klotho in aging and neurodegeneration in particular has gained considerable attention. In this narrative review we highlight several key insights into the molecular basis and physiological function of Klotho and synthesize current research on the role of Klotho in neurodegeneration and aging. Klotho deficiency was associated with cognitive impairment, reduced growth, diminished longevity and the development of age-related diseases in vivo. Serum Klotho levels showed a decline in individuals with advanced age and those affected by chronic kidney disease, establishing its potential diagnostic significance. Additionally, multiple medications have been demonstrated to influence Klotho levels. Therefore, this comprehensive review suggests that Klotho could open the door to novel interventions aimed at addressing the challenges of aging and neurodegenerative disorders.
Unless your potassium levels are above 5.0, most nephrologists have no idea what to say, but they feel the need to fill the air with vibrations, so they make sound.
And people wonder why I call the ones at the dialysis center "drive by doctors". They come by with their laptop on a rolling cart and one of the nurses tags along. They stop at each chair and ask "how is dialysis going". Visits typically last 5 min or less. This month I only "saw" my nephrologist via a tablet...he didn't even come in an make vibrations.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
New to CKD
CKD & autoimmune disease
Is anyone with CKD on Clonidine b/p drug?
Stage 5 CKD with no warning
